FDA Press Announcements · September 4, 2026 · Primary source
September 4, 2026 - FDA Grants Accelerated Approval to a New Breast Cancer Treatment
Read the full document at FDA Press Announcements.
Related items
- FDA Recalls · August 20, 2026Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin LevelsScore 68
- FDA Press Announcements · October 5, 2026FDA Seeks Public Input to Support Ibogaine ResearchScore 58
- FDA Recalls · August 24, 2026Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super PotencyScore 50
- FDA Recalls · August 28, 2026B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate MatterScore 48
- FDA Press Announcements · October 24, 2026FDA Issues Final Guidance on Prescription Drug Apps and SoftwareScore 46
- FDA Recalls · September 4, 2026American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of SterilityScore 46